What Requires Your Direct Confirmation Here's what a review of Sunlight's publicly available materials can and can't confirm: What could be verified: Legal operator identity (GLP-1, LLC d/b/a Sunlight.com, LLC), address, contact information - verified from Terms of Use Named medical team members and their stated credentials - verifiable through board certification registries Named pharmacy partners and their published addresses - verifiable through state pharmacy board registries Pricing ($159 semaglutide / $239 tirzepatide starting price) - confirmed on brand's FAQ Medications offered (compounded semaglutide and tirzepatide) - confirmed FDA non-approval of compounded GLP-1 products - confirmed by brand's own disclaimers and FDA policy Subscription and cancellation terms - confirmed from Terms of Use Refund policy (no refund once prescription written) - confirmed from Terms of Use LegitScript certification claim - brand states this
Reduced appetite : Whilst this is the intended therapeutic effect, some patients may find it excessive
We invite you to schedule a consultation at our clinic to discuss whether GLP-1 medications might benefit your health situation
Final thoughts Stopping GHK-Cu typically produces gradual benefit decline over 2-4 months without dramatic rebound effects or rapid reversal to pre-treatment baseline, with 30-40% of long-term users (6+ months treatment) maintaining 50-70% of peak improvements indefinitely while shorter-term users show greater regression toward baseline
Furthermore, positive correlations among the sputum NSPs were observed at baseline and in response to treatment at all time points, pointing to the interrelated efficacy of brensocatib on all three NSP activities (202)
